Index Entries

2086 Results
TitleIS Publication Date
Pulmonary embolism after SARS-CoV-2 vaccinationOctober 15, 2024
QCovid algorithm
Quantifying the risk of SARS-CoV-2 reinfection over timeMay 27, 2021
Quantitative evaluation of whether the Nobel-Prize-winning COVID-19 vaccine actually saved millions of livesOctober 8, 2023
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)June 19, 2020
Questions for a Covid-19 Commission2023
Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?May 19, 2023
Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centersJune 21, 2022
Rapid aging, scarring of the arteries: A side effect of the COVID injections (Interview with Arne Burkhardt)May 22, 2024
Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1November 12, 2021
Rapid Expert Consultation on the Effectiveness of Fabric Masks for the Covid-19 PandemicApril 8, 2020
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case ReportNovember 24, 2021
Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case reportJuly 31, 2022
Rapid Response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell usOctober 21, 2020
Rapid Response: Open letter from The BMJ to Mark ZuckerbergDecember 17, 2021
Rapid Response: Psychosocial, biological, and immunological risks for children and pupils make long-term wearing of mouth masks difficult to maintainSeptember 9, 2020
Rapid Response: Why don't Covid-19 vaccine trials report statistics for the first 14 days?March 16, 2021
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 VaccinationOctober 8, 2021
Rate of SARS-CoV-2 Reinfection During an Omicron Wave in IcelandAugust 3, 2022
Rational harm-benefit assessments by age group are required for continued COVID-19 vaccinationDecember 22, 2022
Re-analysis on the statistical sampling biases of a mask promotion trial in Bangladesh: a statistical replicationSeptember 15, 2022
React19
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune DiseasesJanuary 19, 2021
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2June 1, 2021
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance systemOctober 16, 2021
Real Not Rare
Real REACTIONS - Non-profit support organization for the vaccine injured
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal StudyJuly 18, 2024
Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virusMay 13, 2022
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-CoronavirusAugust 2, 2019
Recent progress of graphene oxide as a potential vaccine carrier and adjuvantAugust 2020
Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluationsMarch 26, 2021
Recurrence of Autoimmune Hepatitis After COVID-19 VaccinationMay 25, 2022
Recurrent Myocarditis Following COVID-19 Infection and the mRNA VaccineJuly 7, 2022
Reducing SARS-CoV-2 transmission in the UK: A behavioural science approach to identifying options for increasing adherence to social distancing and shielding vulnerable peopleMay 19, 2020
Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 SubjectsAugust 31, 2022
Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant WomenApril 7, 2022
Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort StudyMarch 15, 2021
Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety DatabaseDecember 19, 2020
Remdesivir for COVID-19: real-time meta analysis of 79 studiesUpdated January 2025
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialApril 29, 2020
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialSeptember 14, 2021
Renal Complications Following COVID-19 Vaccination: A Narrative Literature ReviewApril 7, 2023
Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort StudyJune 16, 2025
Reply to Fung et al. on COVID‐19 vaccine case‐countingwindow biases overstating vaccine effectivenessJuly 4, 2023
Report 12: The Global Impact of COVID-19 and Strategies for Mitigation and SuppressionMarch 26, 2020
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demandMarch 16, 2020
Report an Adverse Event to VAERS
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic ReviewSeptember 20, 2016
Reports of acute adverse events in mRNA COVID‑19 vaccine recipients after the first and second doses in JapanSeptember 15, 2022